The Korean Journal of Food And Nutrition (한국식품영양학회지)

The Korean Society of Food and Nutrition (한국식품영양학회)
권호 표지
DOI QR코드

DOI QR Code

Relation between Serum Uric Acid Levels and Metabolic Syndrome Markers among Koreans by Gender

한국인의 성별에 따른 혈중 요산 농도와 대사증후군 위험 혈액 지표 간의 관련성

  • Park, Hyunjin (ICAN Nutrition Education and Research) ;
  • Ryu, Hyesook (Dept. of Food and Nutrition, Sangji University) ;
  • Jho, Kwanghyun (Dept. of Business Administration, Sahmyook University) ;
  • Ko, Jaeyoung (National Health Insurance Corporation Ilsan Haspital) ;
  • Yun, Mieun (Dept. of Food and Nutrition, Sahmyook University)
  • 박현진 (ICAN 영양연구소) ;
  • 류혜숙 (상지대학교 식품영양학과) ;
  • 조광현 (삼육대학교 경영학과) ;
  • 고재영 (국민건강보험공단 일산병원영양팀) ;
  • 윤미은 (삼육대학교 식품영양학과)
  • Received : 2016.06.03
  • Accepted : 2016.08.26
  • Published : 2016.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

It has been reported that the increased uric acid level is associated with metabolic syndrome risk factors in both male and female. However, there has not been enough studies to investigate gender differences of this association in Korea. To evaluate relation between serum uric acids and metabolic syndrome markers, anthropometric and biochemical analyses data was obtained from National Health Examination 2005 and 5,523 (M=3,097; F=2,426) data was analyzed. Results by quartile of serum uric acid levels in females showed that increased serum uric acid level was associated with elevated levels of total-. LDL-cholesterol, and triglycerides, whereas association between serum uric acid and total cholesterol levels was not observed in male subjects. In both female and male, higher quartile of serum uric acid level were linked with lower levels of HDL-cholesterol. In regression analysis, association of serum uric acid levels with fasting glucose levels was significant in female subjects only. In conclusion, higher serum uric acid levels were associated with metabolic syndrome indices, however gender differences were existed for total cholesterol.

Keywords

References

  1. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. 2005. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450-2461 https://doi.org/10.1056/NEJMoa050373
  2. Billiet L, Doaty S, Katz JD, Velasquez MT. 2014. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 16:852954
  3. Carbone F, Montecucco F, Mach F, Pontremoli R, Viazzi F. 2013. The liver and the kidney: Two critical organs influencing the atherothrombotic risk in metabolic syndrome. Thromb Haemost 110:940-958 https://doi.org/10.1160/TH13-06-0499
  4. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. 2005. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 183:147-155 https://doi.org/10.1016/j.atherosclerosis.2005.01.018
  5. Ding X, Zeng C, Wei J, Li H, Yang T, Zhang Y, Xiong YL, Gao SG, Li YS, Lei GH. 2016. The associations of serum uric acid level and hyperuricemia with knee osteoarthritis. Rheumatol Int 36:567-573 https://doi.org/10.1007/s00296-015-3418-7
  6. Feig DI, Kang DH, Johnson RJ. 2008. Uric acid and cardiovascular risk. N Engl J Med 359:1811-1821 https://doi.org/10.1056/NEJMra0800885
  7. Gagliardi AC, Miname MH, Santos RD. 2009. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 202:11-17 https://doi.org/10.1016/j.atherosclerosis.2008.05.022
  8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando C. 2005. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement: Executive summary. Crit Pathw Cardiol 4:198-203 https://doi.org/10.1097/00132577-200512000-00018
  9. Hediger MA, Johnson RJ, Miyazaki H, Endou H. 2005. Molecular physiology of urate transport. Physiology (Bethesda) 20:125-133 https://doi.org/10.1152/physiol.00039.2004
  10. Hyun DW, Kim KH, Yoon HJ, Kwon TG, Kim KY, Bae JH. 2007. Gender differences in the role of serum uric acid for predicting cardiovascular events in patients with coronary artery disease. Korean Circulation J 37:196-201 https://doi.org/10.4070/kcj.2007.37.5.196
  11. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. 2003. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183-1190 https://doi.org/10.1161/01.HYP.0000069700.62727.C5
  12. Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:e943162
  13. Kawabe M, Sato A, Hoshi T, Sakai S, Hiraya D, Watabe H, Kakefuda Y, Ishibashi M, Abe D, Takeyasu N, Aonuma K. 2016. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome. J Cardiol 67:170-176 https://doi.org/10.1016/j.jjcc.2015.05.009
  14. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. 2009. Hyperuricemia and risk of stroke: A systematic review and meta-analysis. Arthritis Rheum 61:885-892 https://doi.org/10.1002/art.24612
  15. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. 2010. Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170-180
  16. Lee YH, Yoon SJ, Kim HS, Oh SW, Ryu HS, Choo JA, Kim SN, Kim YA, Park MS, Park YS, Kim SY, Kwon AR. 2013. Design and preliminary results of a metropolitan lifestyle intervention program for people with metabolic syndrome in South Korea. Diabetes Res Clin Pract 101:293-302 https://doi.org/10.1016/j.diabres.2013.06.006
  17. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, Zhang C. 2013. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLoS One 8:e56864 https://doi.org/10.1371/journal.pone.0056864
  18. Nashar K, Fried LF. 2012. Hyperuricemia and the progression of chronic kidney disease: Is uric acid a marker or an independent risk factor? Adv Chronic Kidney Dis 19:386-91 https://doi.org/10.1053/j.ackd.2012.05.004
  19. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, Yazici M, Keles I. 2006. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19:1055-1062 https://doi.org/10.1016/j.amjhyper.2006.02.014
  20. Puig JG, Martinez MA. 2008. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 20:187-191 https://doi.org/10.1097/BOR.0b013e3282f4b1ed
  21. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. 1998. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Ann Epidemiol 8:250-261
  22. Richette P, Bardin T. 2010. Gout. Lancet 375:318-328 https://doi.org/10.1016/S0140-6736(09)60883-7
  23. Tuttle KR, Short RA, Johnson RJ. 2001. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87:1411-1414 https://doi.org/10.1016/S0002-9149(01)01566-1
  24. Viazzi F, Leoncini G, Vercelli M, Deferrari G, Pontremoli R. 2011. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: The MAGIC study. Diabetes Care 34:126-128 https://doi.org/10.2337/dc10-0918
  25. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. 2005. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928-933 https://doi.org/10.1253/circj.69.928
  26. Zhou Y, Wei F, Fan Y. 2016. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Biochem 49:636-642 https://doi.org/10.1016/j.clinbiochem.2015.12.010